TIFFANY ABODE: Open Payments
NPI 1184234445 · MANALAPAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 18 payments from 13 companies in 2025. Trend: 2023 $367 · 2024 $316 · 2025 $1,133
Food & beverage: $664Travel & lodging: $470
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $470 |
| Edwards Lifesciences Corporation | 1 | $190 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Boston Scientific Corporation | 1 | $103 |
| Imperative Care, Inc | 3 | $70 |
| United Therapeutics Corporation | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| Chiesi USA, Inc. | 1 | $22 |
| AtriCure, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Barostim Neo System, PASCAL, AMVUTTRA, General - CRM_CRM, Tyvaso, UPTRAVI, PRODIGY CATHETER, SYMPHONY CATHETER.
Industry payments across NJ — which companies pay providers there.
